Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Keegan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
European Journal of Medicinal Chemistry|May 6, 2014
Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitorsAndreas Reichelt, Julie M Bailis, Michael D Bartberger, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)D A Johnson, C G Sowell, C L Johnson, et al.
Biochimica Et Biophysica Acta. General Subjects|January 19, 2020
Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibitionAlbert Liclican, Loredana Serafini, Weimei Xing, et al.
Genes & Development|October 1, 1996
The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomesK S Keegan, D A Holtzman, A W Plug, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of an Atropisomeric PI3Kβ Selective Inhibitor through Optimization of the Hinge Binding MotifStephane Perreault, Fatima Arjmand, Jayaraman Chandrasekhar, et al.
Journal of Medicinal Chemistry|January 21, 2017
Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856Stephane Perreault, Jayaraman Chandrasekhar, Zhi-Hua Cui, et al.
Journal of Medicinal Chemistry|December 2, 1999
3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activitiesD A Johnson, D S Keegan, C G Sowell, et al.
Cancer Discovery|September 27, 2018
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established TherapiesSean Caenepeel, Sean P Brown, Brian Belmontes, et al.
Journal of Medicinal Chemistry|March 20, 2014
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3Zhihong Li, Xianghong Wang, John Eksterowicz, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Journal of Medicinal Chemistry|May 6, 2014
Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitorsAndreas Reichelt, Julie M Bailis, Michael D Bartberger, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)D A Johnson, C G Sowell, C L Johnson, et al.
Biochimica Et Biophysica Acta. General Subjects|January 19, 2020
Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibitionAlbert Liclican, Loredana Serafini, Weimei Xing, et al.
Genes & Development|October 1, 1996
The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomesK S Keegan, D A Holtzman, A W Plug, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of an Atropisomeric PI3Kβ Selective Inhibitor through Optimization of the Hinge Binding MotifStephane Perreault, Fatima Arjmand, Jayaraman Chandrasekhar, et al.
Journal of Medicinal Chemistry|January 21, 2017
Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856Stephane Perreault, Jayaraman Chandrasekhar, Zhi-Hua Cui, et al.
Journal of Medicinal Chemistry|December 2, 1999
3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activitiesD A Johnson, D S Keegan, C G Sowell, et al.
Cancer Discovery|September 27, 2018
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established TherapiesSean Caenepeel, Sean P Brown, Brian Belmontes, et al.
Journal of Medicinal Chemistry|March 20, 2014
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3Zhihong Li, Xianghong Wang, John Eksterowicz, et al.
Pageof 3